296 related articles for article (PubMed ID: 17081685)
1. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer.
Darvishi K; Sharma S; Bhat AK; Rai E; Bamezai RN
Cancer Lett; 2007 May; 249(2):249-55. PubMed ID: 17081685
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial genetic background modifies breast cancer risk.
Bai RK; Leal SM; Covarrubias D; Liu A; Wong LJ
Cancer Res; 2007 May; 67(10):4687-94. PubMed ID: 17510395
[TBL] [Abstract][Full Text] [Related]
3. Germline HVR-II mitochondrial polymorphisms associated with breast cancer in Tunisian women.
Yacoubi Loueslati B; Troudi W; Cherni L; Rhomdhane KB; Mota-Vieira L
Genet Mol Res; 2010 Aug; 9(3):1690-700. PubMed ID: 20812191
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Elhan AH; Karakaya AE
Cell Biochem Funct; 2005; 23(1):73-6. PubMed ID: 15386537
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
[TBL] [Abstract][Full Text] [Related]
7. p53 genotypes and haplotypes associated with risk of breast cancer.
Buyru N; Altinisik J; Demokan S; Dalay N
Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
[TBL] [Abstract][Full Text] [Related]
8. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Hum Immunol; 2008 Mar; 69(3):179-86. PubMed ID: 18396210
[TBL] [Abstract][Full Text] [Related]
9. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients.
Gochhait S; Bhatt A; Sharma S; Singh YP; Gupta P; Bamezai RN
Int J Cancer; 2008 Dec; 123(11):2580-6. PubMed ID: 18792899
[TBL] [Abstract][Full Text] [Related]
10. [Polymorphism of the mitochondrial microsatellite 303-315 in breast cancer in Tunisia].
Yacoubi-Loueslati B; Troudi W; Baccar A; Cherni L; Rhomdhane KB; Elgaaied AB
Bull Cancer; 2009 Mar; 96(3):337-42. PubMed ID: 19318312
[TBL] [Abstract][Full Text] [Related]
11. Can mitochondrial DNA mutations in circulating white blood cells and serum be used to detect breast cancer?
Losanoff JE; Zhu W; Qin W; Mannello F; Sauter ER
Breast; 2008 Oct; 17(5):540-2. PubMed ID: 18571924
[TBL] [Abstract][Full Text] [Related]
12. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
13. The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved.
Guardado-Estrada M; Medina-Martínez I; Juárez-Torres E; Roman-Bassaure E; Macías L; Alfaro A; Alcántara-Vázquez A; Alonso P; Gomez G; Cruz-Talonia F; Serna L; Muñoz-Cortez S; Borges-Ibañez M; Espinosa A; Kofman S; Berumen J
J Hum Genet; 2012 Apr; 57(4):269-76. PubMed ID: 22357541
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
15. Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany.
Wang-Gohrke S; Chang-Claude J
Breast Cancer Res Treat; 2004 Dec; 88(3):231-7. PubMed ID: 15609125
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC
Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835
[TBL] [Abstract][Full Text] [Related]
18. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women.
Wang-Gohrke S; Rebbeck TR; Besenfelder W; Kreienberg R; Runnebaum IB
Anticancer Res; 1998; 18(3B):2095-9. PubMed ID: 9677474
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H.
Palacín M; Alvarez V; Martín M; Díaz M; Corao AI; Alonso B; Díaz-Molina B; Lozano I; Avanzas P; Morís C; Reguero JR; Rodríguez I; López-Larrea C; Cannata-Andía J; Batalla A; Ruiz-Ortega M; Martínez-Camblor P; Coto E
Mitochondrion; 2011 Jan; 11(1):176-81. PubMed ID: 20863902
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population.
Niemi AK; Hervonen A; Hurme M; Karhunen PJ; Jylhä M; Majamaa K
Hum Genet; 2003 Jan; 112(1):29-33. PubMed ID: 12483296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
